Omega-3 fatty acids
- Generic Name
- Omega-3 fatty acids
- Brand Names
- Animi-3 With Vitamin D, Vitafol-one
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 329042-31-1
- Unique Ingredient Identifier
- 71M78END5S
- Background
Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that origin...
- Indication
Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia.
- Associated Conditions
- -
- Associated Therapies
- Nutritional supplementation, Parenteral Nutrition
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
- Conditions
- Interventions
- First Posted Date
- 2020-08-19
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Shanghai Mental Health Center
- Target Recruit Count
- 120
- Registration Number
- NCT04518319
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses
- Conditions
- Interventions
- First Posted Date
- 2019-11-13
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 80
- Registration Number
- NCT04161989
- Locations
- 🇪🇬
Women Health Hospital - Assiut university, Assiut, Egypt
Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD
- Conditions
- Interventions
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 35
- Registration Number
- NCT03784963
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- Conditions
- Interventions
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 153
- Registration Number
- NCT03510884
- Locations
- 🇪🇸
Investigational Site Number :7240003, Pamplona, Navarra, Spain
🇵🇱Investigational Site Number :6160002, Gdansk, Pomorskie, Poland
🇲🇽Investigational Site Number :4840007, Oaxaca, Mexico
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 18
- Registration Number
- NCT03510715
- Locations
- 🇩🇰
Investigational Site Number 2080001, Viborg, Denmark
🇪🇸Investigational Site Number 7240001, A Coruna, Spain
🇸🇮Investigational Site Number 7050001, Ljubljana, Slovenia
The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
- Conditions
- Interventions
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 309
- Registration Number
- NCT03120299
- Locations
- 🇨🇳
Ruijin hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, Shanghai, China
Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis
- Conditions
- Interventions
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Target Recruit Count
- 44
- Registration Number
- NCT03006016
- Locations
- 🇫🇷
CHU de Nice - Chirurgie Digestive- Hôpital Archet, Nice, Alpes-maritimes, France
🇫🇷CHU de Montpellier - Chirurgie digestive, Montpellier, Languedoc - Roussillon, France
Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02899741
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 42
- Registration Number
- NCT02890992
- Locations
- 🇨🇿
Investigational Site Number 2030002, Zlin, Czechia
🇺🇸Investigational Site Number 8400005, Charlotte, North Carolina, United States
🇺🇸Investigational Site Number 8400001, Cincinnati, Ohio, United States
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
- Conditions
- Interventions
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 2232
- Registration Number
- NCT02757872
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.